Amiodarone-induced alveolar hemorrhage

Southern Medical Journal
Said B IskandarThomas M Roy

Abstract

Amiodarone is increasingly prescribed for patients with ventricular and supraventricular tachyarrhythmias. Many adverse effects have been reported due to this drug and include injury to the liver, thyroid, cornea, skin, and neuromuscular system. Pulmonary toxicity is one of the more serious side effects of this anti-arrhythmic drug and is potentially fatal. Since the first case of amiodarone-induced pneumonitis was described in the early 1980s, amiodarone pneumonitis has been recognized as a distinctive and not uncommon form of drug-induced lung injury. On the other hand, amiodarone-induced pulmonary toxicity resulting in alveolar hemorrhage is rare. The authors report a patient with amiodarone-induced alveolar hemorrhage and review the literature.

References

Sep 1, 1988·Journal of the American College of Cardiology·S A MagroC R Wyndham
Jan 1, 1987·American Journal of Clinical Pathology·P J DeanE B Golden
Sep 1, 1984·Chest
Oct 1, 1984·Chest·P J KudenchukG B Trobaugh
Jul 1, 1984·Chest·J R SpurzemJ W Shigeoka
Mar 31, 1983·The New England Journal of Medicine·C ZaherW Mandel
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Mar 1, 1995·The European Respiratory Journal·J M ValleL Valdés
Apr 1, 1994·The Annals of Pharmacotherapy·R GutierrezE Jimenez
Jan 1, 1994·Chest·L D Vizioli, S Cho
Jan 1, 1993·Southern Medical Journal·A E FraireM H Chasen
Jun 29, 1999·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·S IskanderA E Iskandrian
Nov 11, 1999·Circulation·S J Connolly
Feb 10, 2000·Current Opinion in Cardiology·G V NaccarelliJ C Luck
Feb 9, 2002·Chest·Madathil Govindaraj
Jan 14, 2004·Chest·Stephen A OlenchockJoseph M Zasik
Jan 14, 2004·Chest·P S SriramJohn G Mastronarde
Apr 6, 2004·Clinics in Chest Medicine·Ulrich CostabelJosune Guzman
Apr 6, 2004·Clinics in Chest Medicine·Philippe CamusEdward C Rosenow
Apr 14, 2004·Chest·Thys van der Molen
Apr 14, 2004·Chest·Allen Brinker, Michael Johnston

❮ Previous
Next ❯

Citations

Apr 26, 2006·Southern Medical Journal·Sonal Singh
Aug 30, 2008·The American Journal of Surgical Pathology·Ruchira Ruangchira-UraiEugene J Mark
Feb 14, 2012·Expert Opinion on Drug Safety·Pasquale SantangeliAndrea Natale
Apr 2, 2010·Heart, Lung & Circulation·Tanyanan TanawuttiwatMohammad Z Sahloul
Jan 9, 2016·Respiratory Medicine Case Reports·Robert SogomonianTerence McGarry
Sep 22, 2007·Seminars in Diagnostic Pathology·Chih-wei Wang, Thomas V Colby
Apr 22, 2015·Revue des maladies respiratoires·A ParrotJ Cadranel
Jan 17, 2017·Internal Medicine·Yoritake SakodaTakafumi Matsumoto
Jun 18, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Spyros A PapirisEffrosyni D Manali
May 22, 2019·Clinical Case Reports·Peter Henry Waddingham, Anthony Wai-Cheong Chow
Jul 2, 2019·Journal of Community Hospital Internal Medicine Perspectives·David HaoJames Kim
Dec 3, 2020·Journal of Cardiothoracic and Vascular Anesthesia·Eric T FeduskaJordan E Goldhammer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Wissam I KhalifeBiswajit Kar
© 2022 Meta ULC. All rights reserved